Alexus Williams

North America Legal Chronicle. August 3, 2023

Alexion, AstraZeneca Rare Disease in Deal with Pfizer

By Leila Ahmed

Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer. AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Duke Energy’s $2.1 Billion First Mortgage Bond Offerings

QXO’s $11 Billion Acquisition of Beacon Roofing Supply

Vice Media’s Acquisition of London Alley Entertainment

FMO’s US$23 Million Trade Facility to Volcafe

Carozzi’s Acquisition of 24.38% of the Shares of Empresas Carozzi

Cemig Geração e Transmissão’s R$625 Million Debentures Issuance

bd-capital’s €430 Million Final Closing of bd-capital Fund 2

Alight’s Acquisition of Lidso Solar Park

Wessex Water Services Ltd’s £600 Million Notes Issuance

2PointZero’s Acquisition of Maseera Holding

Hyde Park Developments’ EGP2.6 Billion Medium-Term Financing

SolarAfrica Energy’s Financing of 114 MW SunCentral 1 PV Plant and Main Transmission Substation

Impact46’s $244 Million Sale of Shares in Rasan Information Technology

Benefit Systems’ Acquisition of Mars Spor Kulübü

Tabreed’s US$1.5 Billion Trust Certificate Issuance Programme and US$700 Million Green Certificates Issuance

Metal Powder Works’ Initial Public Offering

Navinci Global Markets’ Acquisition of Flight Simulation Business from Rex Airlines

Egis Group’s Dual Acquisitions of the Engeny and Peracon

Nelson Wilians Advogados advises on structuring innovative CRI with tokenization potential

Cleary Gottlieb Acquires Springbok AI

Supreme Court of El Salvador Blocks Enforcement of Arbitration Order in Continental Towers Dispute

O’Melveny Welcomes Acclaimed Technology Dealmaker Craig Menden

Delfino e Associati Willkie Farr & Gallagher LLP Strengthens its Public Law and International Trade & Compliance Team

Mintz Appoints Head of Innovation, AI, and E-Data Consulting

Alexion, AstraZeneca Rare Disease in Deal with Pfizer

Standard 1 Year Membership Required